Gateway Investment Advisers LLC lowered its position in shares of Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN – Free Report ) by 6.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 915 shares of the biopharmaceutical company's stock after selling 58 shares during the quarter. Gateway Investment Advisers LLC's holdings in Regeneron Pharmaceuticals were worth $657,000 as of its most recent SEC filing.

https://www.dailypolitical.com/2023/09/24/gateway-investment-advisers-llc-lowers-stake-in-regeneron-pharmaceuticals-inc-nasdaqregn.html

#dailypolitical